Delivery Order SPE2DB25D3108-SPE2DB25FPDWE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Prevymis 480 mg tablets in seven-tablet packages, with a contract ceiling value of $9,438.70 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's ongoing...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prevymis 480 mg tablets (7-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 10, 2025, and represents a child order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Prevymis 480 mg tablets in a quantity of seven units, with a total ceiling value of $4,719.34. This firm fixed-price delivery order is scheduled for completion by October 2, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count packages) on September 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 29, 2025, represents a non-competitive award utilizing AmerisourceBergen's existing contract vehicle. The pharmaceutical distributor will perform this delivery from its corporate office location in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) valued at $4,719.34. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven units. This competitively awarded, firm fixed-price contract carries a ceiling value of $9,438.70 and is scheduled for completion by August 22, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging). This is a firm fixed-price contract with an ultimate completion date of August 15, 2025, and represents a non-set-aside, competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Prevymis 480 mg tablets in quantities of seven units. The contract carries a ceiling value of $9,438.70 under firm fixed price terms, with an ultimate completion date of October 16, 2025. This delivery order represents a child contract executed under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,719.34 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (7-count units) with an ultimate completion date of August 25, 2025. This is a firm fixed price, non-set-aside contract that represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $4.7K delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Prevymis 480 mg tablets (7-count packaging). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDWEDelivery Order
The Defense Logistics Agency awarded a $4,719.34 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Prevymis 480 mg tablets (quantity: 7 units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and vaccines. AmerisourceBergen's substantial federal contract portfolio and competitive positioning reflect its critical role in supporting Defense Health Agency and other government healthcare system requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 9/5/25 |